Wedge Capital Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.62M Sell
110,508
-3,913
-3% -$141K 0.06% 241
2026
Q1
$4.05M Sell
114,421
-16
-0% -$651 0.07% 227
2025
Q4
$4.65M Buy
114,437
+71,282
+165% +$3.1M 0.08% 221
2025
Q3
$2.03M Buy
43,155
+9,329
+28% +$484K 0.03% 349
2025
Q2
$1.76M Sell
33,826
-520
-2% -$28.5K 0.03% 343
2025
Q1
$2.07M Sell
34,346
-10,031
-23% -$647K 0.04% 315
2024
Q4
$3.04M Sell
44,377
-112
-0.3% -$7.8K 0.05% 274
2024
Q3
$3.2M Buy
+44,489
New +$3.14M 0.06% 269
2016
Q2
Sell
-8,326
Closed -$349K 568
2016
Q1
$349K Sell
8,326
-1,624
-16% -$63.7K ﹤0.01% 489
2015
Q4
$438K Buy
9,950
+1,525
+18% +$66.2K ﹤0.01% 463
2015
Q3
$402K Buy
8,425
+2,325
+38% +$128K ﹤0.01% 475
2015
Q2
$355K Buy
6,100
+525
+9% +$28.3K ﹤0.01% 500
2015
Q1
$281K Hold
5,575
﹤0.01% 546
2014
Q4
$251K Sell
5,575
-1,425
-20% -$59.7K ﹤0.01% 554
2014
Q3
$258K Buy
7,000
+1,600
+30% +$63.5K ﹤0.01% 542
2014
Q2
$238K Buy
+5,400
New +$245K ﹤0.01% 541

Other funds holding CNMD

Wedge Capital Management's CNMD Position: Q2 2026 in Review

Wedge Capital Management reduced its CONMED (CNMD) stake by 3.4% in Q2 2026, selling an estimated $141K and leaving 110,508 shares worth $3.62M. The position accounts for 0.06% of the portfolio, ranked #241.

Wedge Capital Management first reported a position in CNMD in Q2 2014 and has held it in 16 quarters since. The position peaked at $4.65M in Q4 2025. 42 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Wedge Capital Management held 110,508 shares of CONMED worth $3.62M as of Q2 2026.
  • Wedge Capital Management sold 3,913 CONMED shares in Q2 2026, an estimated $141K.
  • CONMED made up 0.06% of Wedge Capital Management's portfolio in Q2 2026, its #241 holding.
  • Wedge Capital Management first reported a position in CONMED in Q2 2014 and has held it in 16 quarters since.
  • Wedge Capital Management's CONMED position peaked at $4.65M in Q4 2025.
  • 42 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.